Bandingkan Harga & Kinerja Multi Bintang Indonesia Tbk. (MLBI) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Multi Bintang Indonesia Tbk. dan Organon Pharma Indonesia Tbk.: Multi Bintang Indonesia Tbk. diperdagangkan di Rp6.800 (kapitalisasi pasar 14,38 T, volume 24 jam 58,9 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Multi Bintang Indonesia Tbk. jauh lebih besar — sekitar 137,7× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| MLBI | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 14,38 T | 104,4 M |
Volume | 58,9 rb | — |
Lot | 589 | — |
Perputaran | 400,52 jt | — |
Harga Rata-rata | 6.799,92 | — |
Nilai Transaksi | 400,52 jt | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Multi Bintang Indonesia Tbk.
PT Multi Bintang Indonesia Tbk (The Company) was established on June 3, 1929, based on notarial deed No. 8 of Tjeerd Dijkstra, notary public in Medan, under the name of NV Nederlandsch Indische Bierbrouwerijen. The Company is part of the Heineken Group, where the ultimate shareholder is Heineken N.V. (Heineken).
Selengkapnya di halaman MLBI →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
